# Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy

> **NCT03724097** · — · UNKNOWN · sponsor: **OmicsWay Corp.** · enrollment: 200 (estimated)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** RNA sequencing
- **OTHER:** Transcriptome analysis
- **DRUG:** target drug with the score above 0,1
- **DRUG:** target drug with the score equal or below 0,1
- **DRUG:** non-target drug
- **DRUG:** palliative care

## Key facts

- **NCT ID:** NCT03724097
- **Lead sponsor:** OmicsWay Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-17
- **Primary completion:** 2021-04-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-09-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03724097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03724097, "Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03724097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*